000 01138 a2200337 4500
005 20250515031439.0
264 0 _c20070808
008 200708s 0 0 ger d
022 _a0020-9554
024 7 _a10.1007/s00108-006-1622-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHiddemann, W
245 0 0 _a[Risk-adapted therapy of acute myeloid leukemia].
_h[electronic resource]
260 _bDer Internist
_cJun 2006
300 _aS33-9 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article; Review
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aLeukemia, Myeloid, Acute
_xclassification
650 0 4 _aPractice Guidelines as Topic
650 0 4 _aPractice Patterns, Physicians'
650 0 4 _aRisk Assessment
_xmethods
650 0 4 _aRisk Factors
700 1 _aSpiekermann, K
700 1 _aBraess, J
700 1 _aFeuring-Buske, M
700 1 _aBuske, C
700 1 _aBüchner, T
773 0 _tDer Internist
_gvol. 47 Suppl 1
_gp. S33-9
856 4 0 _uhttps://doi.org/10.1007/s00108-006-1622-y
_zAvailable from publisher's website
999 _c16368345
_d16368345